Itm2b Amyloidosis

Watchlist
Retrieved
2021-01-23
Source
Trials
Drugs

A rare, neurodegenerative disease characterized by progressive dementia and ataxia, widespread cerebral amyloid angiopathy and parenchymal amyloid deposition. Two subtypes have been identified, ABri amyloidosis and ADan amyloidosis.